Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors

NCT00005590 is registered in ClinicalTrials.gov with Cancer Research Campaign Clinical Trials Centre as lead sponsor.

NCT NCT00005590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors
Lead sponsor
Cancer Research Campaign Clinical Trials Centre
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1999
Completion date
September 30, 2005
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, breast cancer, extragonadal germ cell tumor, infection, lung cancer, lymphoma, ovarian cancer, small intestine cancer, testicular germ cell tumor, unspecified adult solid tumor, protocol specific